A recent pathologic-imaging correlation study of [18F]THK5351 PET in postmortem patients [28] revealed that both Tau burden and astrogliosis affect [18F]THK5351 PET uptake in AD patients. The gene discussed is MAPT; the disease is Alzheimer disease.